A diazaborine derivative inhibits lipopolysaccharide biosynthesis.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001896:Boron Compounds / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis*; D012486:Salmonella typhimurium / Q000187:drug effects; D013400:Sugar Acids / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001896:Boron Compounds; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D013400:Sugar Acids; C002532:2-keto-3-deoxyoctonate; C032255:1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2D)(1,2,3)-diazaborine